US Patent

US12128137 — Topical compositions and methods for treating skin diseases

Method of Use · Assigned to Bausch Health Ireland Ltd · Expires 2038-05-11 · 12y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects topical pharmaceutical compositions containing tazarotene or a salt of tazarotenic acid for treating skin diseases like acne vulgaris.

USPTO Abstract

Topical pharmaceutical compositions include tazarotene or a pharmaceutically acceptable salt of tazarotenic acid and an oil-in-water emulsion vehicle that forms a lotion. The compositions are used to treat skin diseases, such as acne vulgaris.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2368`	—

Patent Metadata

Patent number: US12128137
Jurisdiction: US
Classification: Method of Use
Expires: 2038-05-11
Drug substance claim: No
Drug product claim: Yes
Assignee: Bausch Health Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.